Profile picture

Doctor Dimitrios Patoulias

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)
Follow
Logo ESC

Contributor content

Sodium-glucose co-transporter-2 inhibitors improve cardiovascular outcomes in heart failure with reduced ejection fraction regardless of ischemic etiology
Presentation
Sodium-glucose co-transporter-2 inhibitors improve cardiovascular outcomes in heart failure with reduced ejection fraction regardless of ischemic etiology
Read more
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
Presentation
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
Read more
Meta-analysis assessing cardiovascular outcomes with febuxostat versus allopurinol for patients with gout
Presentation
Meta-analysis assessing cardiovascular outcomes with febuxostat versus allopurinol for patients with gout
Read more
Effect of sodium-glucose co-transporter 2 inhibitors on left ventricular mass and left atrial volume indices assessed either by cardiovascular magnetic resonance or transthoracic echocardiography
Presentation
Effect of sodium-glucose co-transporter 2 inhibitors on left ventricular mass and left atrial volume indices assessed either by cardiovascular magnetic resonance or transthoracic echocardiography
Read more

ESC 365 is supported by

novartis Explore sponsored resources